Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?

about

High-throughput sequencing for noninvasive disease detection in hematologic malignancies.HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data.A Next-Generation Sequencing Primer-How Does It Work and What Can It Do?

P2860

Q38672646-87441C13-187E-422E-B7D2-9BB7FF21C02D Q47423302-1DDD7C8B-2E7C-4844-83E0-88160ECB917F Q54996932-6B1289DE-63DC-4BF2-9AFF-EF1FF6CE8F52

P2860

Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?

Item

http://www.wikidata.org/entity/Q38815331

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Is Next-Generation Sequencing ...... Acute Lymphoblastic Leukemia?

@en

type

Item

label

Is Next-Generation Sequencing ...... Acute Lymphoblastic Leukemia?

@en

prefLabel

Is Next-Generation Sequencing ...... Acute Lymphoblastic Leukemia?

@en

P1476

Is Next-Generation Sequencing ...... Acute Lymphoblastic Leukemia?

@en

P2093

Jan Trka

http://www.w3.org/2001/XMLSchema#string

Michael Kneba

http://www.w3.org/2001/XMLSchema#string

P2860

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

Liquid biopsies: genotyping circulating tumor DNA

Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.

Real time quantitative PCR

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

SASI-Seq: sample assurance Spike-Ins, and highly differentiating 384 barcoding for Illumina sequencing.

ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data.

Detection of minimal residual disease in acute leukemia by flow cytometry.

P2888

s40291-017-0277-9

P304

481-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40291-017-0277-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michaela Kotrova

Monika Brüggemann

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085077581

http://www.w3.org/2001/XMLSchema#string

P698

28452038

http://www.w3.org/2001/XMLSchema#string

Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?

about

P2860

P2860

Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698